ATC
ICPT

Adirondack Trust Company’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Adirondack Trust Company’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35
Closed -$4K – 359
2016
Q4 		$4K Hold
35
– – ﹤0.01% 291
2016
Q3 		$6K Hold
35
– – ﹤0.01% 271
2016
Q2 		$5K Hold
35
– – ﹤0.01% 326
2016
Q1 		$4K Hold
35
– – ﹤0.01% 321
2015
Q4 		$4K Sell
35
-5
-13% -$846 ﹤0.01% 310
2015
Q3 		$7K Buy
+40
New +$8.8K 0.01% 270

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Adirondack Trust Company's ICPT Position: Q1 2017 in Review

Adirondack Trust Company sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2017, closing a stake of 35 shares — an estimated $4K sold.

Adirondack Trust Company first reported a position in ICPT in Q3 2015 and held it in 6 quarters. The position peaked at $7K in Q3 2015. 150 funds tracked by Wall St. Rank hold ICPT as of Q1 2017.

  • Adirondack Trust Company reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Adirondack Trust Company sold 35 Intercept Pharmaceuticals, Inc. shares in Q1 2017, an estimated $4K.
  • Adirondack Trust Company first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
  • Adirondack Trust Company's Intercept Pharmaceuticals, Inc. position peaked at $7K in Q3 2015.
  • 150 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2017.

Based on Adirondack Trust Company's 13F filing for Q1 2017, filed 12 Apr 2017.